Control Bionics (ASX: CBL) registers NeuroStrip with US FDA as commercial execution becomes the next test
Read More Technology Industry News Weebit Nano (ASX:WBT) has ReRAM momentum, but revenue must now justify the valuation Weebit has ReRAM deals, cash and guidance. The bigger test is whether ASX:WBT can turn chip licences into royalty-scale revenue. bySrinathJune 12, 2026